Conavi Medical Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024
Net Income	-17.85	-20.52	-43.62
Depreciation & Amortization	0.7	0.51	0.53
Stock-Based Compensation	0.93	0.44	0.26
Other Adjustments	-1.84	-2.64	17.9
Change in Receivables	0.05	0.69	0.06
Changes in Inventories	0.06	1.27	1.39
Changes in Accounts Payable	-1.6	-4.84	2.45
Changes in Income Taxes Payable	-0.34	0	0.02
Changes in Unearned Revenue	-0.13	0.47	-0.22
Changes in Other Operating Activities	-4.17	-0.79	0.63
Operating Cash Flow	-23.68	-25.1	-20.15
Capital Expenditures	-0.05	-0.07	-0.58
Purchases of Intangible Assets	-0.31	-0.11	-0.27
Other Investing Activities	-	3.75	-
Investing Cash Flow	-0.36	3.57	-0.85
Long-Term Debt Issued	-	-	8.19
Long-Term Debt Repaid	-0.72	-0.55	-0.62
Net Long-Term Debt Issued (Repaid)	-0.72	-0.55	7.58
Issuance of Common Stock	17.47	28.47	0.01
Net Common Stock Issued (Repurchased)	17.47	28.47	0.01
Other Financing Activities	-0.99	-0.98	-0.32
Financing Cash Flow	27.5	26.94	7.26
Net Cash Flow	3.46	5.41	-13.73
Free Cash Flow	-23.74	-25.17	-20.72
FCF Margin	-3050.90%	-275.96%	-958.95%
Free Cash Flow Per Share	-0.29	-0.44	-0.36
Levered Free Cash Flow	-28.18	-13	-5.13
Unlevered Free Cash Flow	-24.6	-23.29	-22.01